Ovarian tumour gene profile revealedOverexpression of certain proteins may guide chemotherapy Fertility-sparing procedure safe in cervical cancerCanadian data support trachelectomy use in younger women Bladder cancer referrals blocked? Few Canadians getting neoadjuvant management, study shows Unintended tumour morcellation proves deadly Users of minimally invasive technique ‘hovering on the brink of safety’ Cetuximab fails in treating advanced cervical cancer Benefit in tumours with squamous cell histology not ruled out Robot negates need for thrombosis prophylaxis Venous thromboembolism rates low after endometrial cancer surgery, suggesting heparin may be unnecessary Pomegranate may increase PSA doubling time Polyphenols and antioxidant in the fruit extract cause improved results Target testing for those at highest risk has value Higher the initial PSA, the greater the risk of aggressive prostate cancer Dutasteride may slow early prostate CA growth A viable alternative for men with low-risk prostate cancer Intermittent ADT as effective as continuous Intermittent androgen deprivation therapy (ADT) may be just as effective as continuous ADT in men with PSA recurrence after radical therapy for prostate cancer, according to a new Canadian study. First Previous 62 63 64 65 66 Next Last
